A leading obesity medicine specialist says new oral GLP-1 drugs offer convenience but generally produce less weight loss than injectable versions like Ozempic. Pills may help patients reluctant to ...
Osstem Implant, a global leader in dental implantation, is significantly expanding its consumer touchpoints to mark its 20th anniversary in India. Moving beyond its core B2B dental equipment business, ...
Ivim Health reports on the effectiveness of GLP-1 pills vs. Ozempic, emphasizing personalized care for obesity management.
Orforglipron is a new oral GLP-1 drug that outperforms oral semaglutide in blood sugar control and weight loss while offering ...
A new research published in the journal of Nephrology showed that desidustat increased hemoglobin levels with acceptable ...
VISAKHAPATNAM: Visakhapatnam-based researcher Madhuri Vissapragada has developed an edible probiotic yogurt-based vaccine ...
April 27 (Reuters) - Oruka Therapeutics said on Monday that interim results showed its experimental drug helped clear psoriasis within 16 weeks, meeting the main goal of a mid-stage study and sending ...
VISAKHAPATNAM: Visakhapatnam-based researcher Madhuri Vissapragada has developed an edible probiotic yogurt-based vaccine ...
But their options are expanding like never before as a wave of new research and therapies are “moving beyond a ‘one-size-fits ...
If you are trying to lose weight, you need to be careful about which supplements you chose since some supplements can cause ...
Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced multiple presentations at the 2026 American ...
The FDA granted fast track designation to KT-621 for treating patients with moderate to severe eosinophilic asthma, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results